Bio-Rad Laboratories, Inc. (BIO) Free Cash Flow (FCF): $374.60M
The free cash flow (FCF) for Bio-Rad Laboratories, Inc. (BIO) is $374.60M. It is above its 12-month average by 16.92% ($320.40M).
BIO Free Cash Flow (FCF) Chart
BIO Average Free Cash Flow (FCF) Chart
BIO Current vs Average Free Cash Flow (FCF) Chart
BIO Free Cash Flow (FCF) Metrics
FREE CASH FLOW (FCF)
$374.60M
FREE CASH FLOW (FCF) AVG TTM
$320.40M
FREE CASH FLOW (FCF) AVG 3Y
$234.84M
FREE CASH FLOW (FCF) AVG 5Y
$325.25M
FREE CASH FLOW (FCF) AVG 10Y
$236.62M
FREE CASH FLOW (FCF) AVG 15Y
$201.01M
FREE CASH FLOW (FCF) AVG 20Y
$182.56M
CURRENT VS TTM AVG
+16.92%
CURRENT VS 3Y AVG
+59.51%
CURRENT VS 5Y AVG
+15.17%
CURRENT VS 10Y AVG
+58.31%
CURRENT VS 15Y AVG
+86.36%
CURRENT VS 20Y AVG
+105.19%
FCF Analysis
Free Cash Flow (TTM)
$374.60M
FCF Yield
4.46%
Price/FCF
22.4
Formula: FCF = Operating Cash Flow - Capital Expenditures
Why FCF matters:
- Shows actual cash available (not accounting earnings)
- Funds dividends, buybacks, and debt reduction
- Less susceptible to accounting manipulation than net income
- Key metric for DCF valuation models
Bio-Rad Laboratories, Inc. Free Cash Flow (FCF) Formula & Definition
Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Bio-Rad Laboratories, Inc. Free Cash Flow (FCF) FAQ
- What is the free cash flow (FCF) for Bio-Rad Laboratories, Inc. (BIO)?
- The free cash flow (FCF) for BIO stock is $374.60M.
- What is the TTM average free cash flow (FCF) for Bio-Rad Laboratories, Inc. (BIO)?
- The TTM average free cash flow (FCF) for BIO stock is $320.40M.
- What is the 3Y average free cash flow (FCF) for Bio-Rad Laboratories, Inc. (BIO)?
- The 3Y average free cash flow (FCF) for BIO stock is $234.84M.
- What is the 5Y average free cash flow (FCF) for Bio-Rad Laboratories, Inc. (BIO)?
- The 5Y average free cash flow (FCF) for BIO stock is $325.25M.
- What is the 10Y average free cash flow (FCF) for Bio-Rad Laboratories, Inc. (BIO)?
- The 10Y average free cash flow (FCF) for BIO stock is $236.62M.
- What is the 15Y average free cash flow (FCF) for Bio-Rad Laboratories, Inc. (BIO)?
- The 15Y average free cash flow (FCF) for BIO stock is $201.01M.
- What is the 20Y average free cash flow (FCF) for Bio-Rad Laboratories, Inc. (BIO)?
- The 20Y average free cash flow (FCF) for BIO stock is $182.56M.
Bio-Rad Laboratories, Inc. Free Cash Flow (FCF) History
| DATE | FREE CASH FLOW (FCF) |
|---|---|
| 2025-12-31 | $374.60M |
| 2024-12-31 | $266.20M |
| 2023-12-31 | $218.26M |
| 2022-12-31 | $80.29M |
| 2021-12-31 | $535.72M |
| 2020-12-31 | $476.41M |
| 2019-12-31 | $359.37M |
| 2018-12-31 | $155.67M |
| 2017-12-31 | $-10.99M |
| 2016-12-31 | $74.50M |
| 2015-12-31 | $72.84M |
| 2014-12-31 | $136.83M |
| 2013-12-31 | $61.78M |
| 2012-12-31 | $121.83M |
| 2011-12-31 | $159.41M |
| 2010-12-31 | $133.38M |
| 2009-12-31 | $248.71M |
| 2008-12-31 | $102.56M |
| 2007-12-31 | $128.91M |
| 2006-12-31 | $65.24M |
| 2005-12-31 | $72.23M |
| 2004-12-31 | $62.60M |
| 2003-12-31 | $58.64M |
| 2002-12-31 | $63.53M |
| 2001-12-31 | $56.27M |
| 2000-12-31 | $-7.16M |
| 1999-12-31 | $-185.10M |
| 1998-12-31 | $6.10M |
| 1997-12-31 | $-33.70M |
| 1996-12-31 | $18.00M |
Related Metrics
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Norman D. Schwartz